Literature DB >> 23086427

Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment.

Joseph E Schumacher1, Cheryl McCullumsmith, Michael J Mugavero, Paige E Ingle-Pang, James L Raper, James H Willig, Zhiying You, D Scott Batey, Heidi Crane, Sarah T Lawrence, Charles Wright, Glenn Treisman, Michael S Saag.   

Abstract

This study described characteristics, psychiatric diagnoses and response to treatment among patients in an outpatient HIV clinic who screened positive for depression. Depressed (25 %) were less likely to have private insurance, less likely to have suppressed HIV viral loads, had more anxiety symptoms, and were more likely to report current substance abuse than not depressed. Among depressed, 81.2 % met diagnostic criteria for a depressive disorder; 78 % for an anxiety disorder; 61 % for a substance use disorder; and 30 % for co-morbid anxiety, depression, and substance use disorders. Depressed received significantly more treatment for depression and less HIV primary care than not depressed patients. PHQ-9 total depression scores decreased by 0.63 from baseline to 6-month follow-up for every additional attended depression treatment visit. HIV clinics can routinely screen and treat depressive symptoms, but should consider accurate psychiatric diagnosis as well as co-occurring mental disorders.

Entities:  

Mesh:

Year:  2013        PMID: 23086427      PMCID: PMC4559144          DOI: 10.1007/s10461-012-0342-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  45 in total

1.  Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study.

Authors:  R L Spitzer; J B Williams; K Kroenke; R Hornyak; J McMurray
Journal:  Am J Obstet Gynecol       Date:  2000-09       Impact factor: 8.661

Review 2.  Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.

Authors:  K Brinkman; H J ter Hofstede; D M Burger; J A Smeitink; P P Koopmans
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

3.  Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting.

Authors:  Sarah T Lawrence; James H Willig; Heidi M Crane; Jiatao Ye; Inmaculada Aban; William Lober; Christa R Nevin; D Scott Batey; Michael J Mugavero; Cheryl McCullumsmith; Charles Wright; Mari Kitahata; James L Raper; Micheal S Saag; Joseph E Schumacher
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

8.  Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population.

Authors:  Katharine A Bradley; Kristen R Bush; Amee J Epler; Dorcas J Dobie; Tania M Davis; Jennifer L Sporleder; Charles Maynard; Marcia L Burman; Daniel R Kivlahan
Journal:  Arch Intern Med       Date:  2003-04-14

9.  The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.

Authors: 
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

10.  Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis.

Authors:  Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog
Journal:  J Psychosom Res       Date:  2003-12       Impact factor: 3.006

View more
  24 in total

1.  Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential.

Authors:  Bradley N Gaynes; Julie O'Donnell; Elise Nelson; Amy Heine; Anne Zinski; Malaika Edwards; Teena McGuinness; Modi A Riddhi; Charita Montgomery; Brian W Pence
Journal:  Gen Hosp Psychiatry       Date:  2015-04-07       Impact factor: 3.238

2.  Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States.

Authors:  Brian W Pence; Jon C Mills; Angela M Bengtson; Bradley N Gaynes; Tiffany L Breger; Robert L Cook; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Michael J Mugavero
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

3.  Efficacy of an evidence-based ARV adherence intervention in China.

Authors:  Ann B Williams; Honghong Wang; Xianhong Li; Jia Chen; Ling Li; Kristopher Fennie
Journal:  AIDS Patient Care STDS       Date:  2014-07-21       Impact factor: 5.078

4.  Depressive Symptoms and Sexually Transmitted Disease: Evidence from a Low-Income Neighborhood of New York City.

Authors:  Boshen Jiao; Zafar Zafari; Kai Ruggeri; Sharifa Z Williams
Journal:  Community Ment Health J       Date:  2019-05-09

5.  Prevalence of Psychiatric and Substance Abuse Symptomatology Among HIV-Infected Gay and Bisexual Men in HIV Primary Care.

Authors:  Conall O'Cleirigh; Jessica F Magidson; Margie R Skeer; Kenneth H Mayer; Steven A Safren
Journal:  Psychosomatics       Date:  2014-08-23       Impact factor: 2.386

6.  The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.

Authors:  Bethany L DiPrete; Brian W Pence; Angela M Bengtson; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Riddhi Modi; Bradley N Gaynes
Journal:  AIDS Behav       Date:  2019-03

7.  Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients.

Authors:  A Norcini Pala; P Steca; R Bagrodia; L Helpman; V Colangeli; P Viale; M L Wainberg
Journal:  Brain Behav Immun       Date:  2016-02-13       Impact factor: 7.217

8.  Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa.

Authors:  R Cholera; B N Gaynes; B W Pence; J Bassett; N Qangule; C Macphail; S Bernhardt; A Pettifor; W C Miller
Journal:  J Affect Disord       Date:  2014-06-12       Impact factor: 4.839

9.  Psychiatric Comorbidity of Unipolar Mood, Anxiety, and Trauma Disorders Prior to HIV Testing and the Effect on Linkage to Care Among HIV-Infected Adults in South Africa.

Authors:  Jennifer M Belus; Rushina Cholera; William C Miller; Jean Bassett; Bradley N Gaynes
Journal:  AIDS Behav       Date:  2019-12

10.  Feasibility, acceptability, and preliminary impact of telemedicine-administered cognitive behavioral therapy for adherence and depression among African American women living with HIV in the rural South.

Authors:  Anna Junkins; Christina Psaros; Corilyn Ott; Andres Azuero; Crystal Chapman Lambert; Karen Cropsey; Robert Savage; Jessica E Haberer; Steven A Safren; Mirjam-Colette Kempf
Journal:  J Health Psychol       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.